Inergetics Inc (fka NRTI)

[crookedneck]

$NRTI - A GOLDEN OPPORTUNITY APPROACHES!

Here are the COLD HARD FACTS that investors/traders need to be aware of, ahead of Inergetics upcoming Spectacular CBD Launch Event in New York City on March 26th!

First, to be very clear, I am only doing what I can to create more exposure for this company that does not partake in any paid promotions or fluff PR's to engage in the unethical games that run rampant in the OTC markets! Their lack of exposure, a huge drop in the MMJ Index last year, and their debt issue from failed past management, have provided a once-in-lifetime opportunity to get in DIRT CHEAP! But let's not forget what big sales and high profit margins can provide to quickly change the financial landscape here. It is not only possible, but in my view, very probable, considering the big competitive advantage they will have by being First-To-Market with their Best-In-Class Quality CBD products with huge Support & Endorsements from the top MMJ industry experts that will set the new gold standard for the entire MMJ retail market. Combine all that with the MMJ Index bottoming and their Spectacular CBD Launch Event to create big exposure, and you have the perfect recipe to reap big returns in a short period of time! Now let's take a more in depth look into all the facts behind this CBD launch and more about the company itself.


The CBD Launch:

On March 26th in NYC, Inergetics will unveil the details for the company's first CBD-based nutraceutical supplement, including branding and distribution will be announced at the invitation-only event for shareholders, the investment community and the news media. "This is an important moment for Inergetics and we are looking forward to sharing information about this new CBD-based product launch as a key step to realizing our vision to bring farm to formula products to market," said Mike James, CEO of Inergetics. With the product's formulation, dosage, naming, brand identity, and regulatory work largely done as well as initial distribution arrangements in place, Inergetics will disclose all the details behind its innovative new pain relief product. Inergetics will also provide a recorded video of the event approximately two weeks after the event available exclusively at www.inergetics.com.

http://finance.yahoo.com/news/inergetics-sets-cbd-product-launch-140000464.html

http://finance.yahoo.com/news/inergetics-completes-final-launch-preparations-140000654.html


SUPPORT & ENDORSEMENTS:

They brought in the most notable authorities in the medical marijuana industry to help create and endorse their one of a kind CBD products that they have also provided the scientific research and medical evidence to support its efficacy and safety. This impressive Scientific/Medical Advisory Board comprised of these top medical and scientific experts from the medical marijuana field played an integral part in assisting Inergetics to create these best in class CBD products for their CBD initiative program, that will lead with a holistic, natural, opiate-free, pain relief supplement.

Dr. Michelle Sexton, who has helped write the monograph on CBD, and who is a highly-respected expert in the medicinal applications of cannabis, naturopathic medicine and the phytochemistry of plant medicine, with more than 15 years of experience in natural, herbal and holistic medicine. She currently serves as the Executive Medical Research Director at the Center for the Study of Cannabis and Social Policy in Seattle. For the past several years, she owned and operated Phytalytics LLC, doing business as PhytaLab, a phytochemical analysis company dedicated to developing and perfecting analytical platforms for the quality control of medical and adult use cannabis and related products in Washington state.

Dr. Yu Shao with extensive experience in product research and development across many areas of health and wellness, specializing in pharmaceutical extraction methods and plant biochemistry – as well as formulating herbal and botanical nutritional products. He brings almost two decades of expertise in these fields working with a variety of global firms, including Glaxo Smith Kline, Wyeth (now Pfizer), and Merck, directing the launch of more than 30 innovative new products for these companies.

Dr. Joseph McSherry, a Neurologist who has extensive knowledge of research involving the medical benefits of cannabis and its cannabinoids for pain management, medicinal and therapeutic use. He is a widely recognized academic expert on medical cannabis/cannabinoids and its many health benefits, and is also involved in several community service initiatives including his service on the State of Vermont's Marijuana Oversight Committee. Dr. McSherry is the author of numerous academic and public presentations on the medical use of cannabis/cannabinoids in general and as it relates to cancer and other specific medical conditions. He received theOutstanding Physician Advocate Award from the Washington, D.C.-based Marijuana Policy Project in 2010.

Dr. Mark Wallace who is an acclaimed anesthesiologist specializing in pain management, with deep experience researching innovative pain treatments and performing in-depth clinical trials on all types of pain. He is board certified in both anesthesiology and pain medicine in the State of California, and is on faculty at the University of California San Diego Health System and the Veterans Affairs San Diego Healthcare System. At UC San Diego, Dr. Wallace serves as the chair of the Division of Pain Medicine and is a Professor of Clinical Anesthesiology. He is also the Director, Division of Clinical Research, UCSD Clinical and Translational Research Institute. He is actively involved in all aspects of clinical care, graduate medical education/training and research. Dr. Wallace's research on pain medicine has been widely published in an extensive array of peer-reviewed medical journals and books. He is also the recipient of numerous grants, including grants from Pfizer, Medtronic and Abbott Laboratories.

Dr. Justin Fischedick is a respected expert in the therapeutic and medicinal properties of chemical components of plants, specifically Cannabis. He brings years of experience in advanced chromatography and spectrometry, including proven abilities in the isolation of natural products for scientific and medical analysis. Dr. Fischedick is currently a Postdoctoral Research Associate at the Institute of Biological Chemistry at Washington State University, and has authored or co-authored several scientific articles on Cannabis, cannabinoids and terpenoids published in top scientific and medical journals. He has presented his scientific research at a number of national and international conferences including the Phytochemical Society of North America conference, the International Conference on Natural Products Research and the International Association for Cannabinoids as Medicine (IACM) conference.

http://finance.yahoo.com/news/inergetics-scientific-medical-advisory-board-130000600.html

http://finance.yahoo.com/news/inergetics-discovers-unique-combination-cannabinoids-140000668.html


QUALITY CONTROL:

They instituted the best possible quality control measures in their manufacturing process to ensure consistent and safe Best-In-Class Quality CBD products for the retail market.

http://finance.yahoo.com/news/inergetics-issues-statement-commitment-best-140000864.html

http://finance.yahoo.com/news/martha-stewart-essentials-named-finalist-130000793.html


They have obtained the purest possible CBD ingredients through an industry approved quality controlled extraction system that is certified to meet their gold standard that will also play a major role in standardizing the entire CBD market, in order to make it a much safer environment overall for the entire CBD field.

http://finance.yahoo.com/news/inergetics-completes-phase-development-therapeutic-140000320.html


DISTRIBUTION:

They have a distribution network already in place to take their CBD products to the retail channels across the US very quickly, far ahead of any other viable competitor on the horizon. (Current brands NRTI has in retail distribution across the US: Bikini Ready, Martha Stewart Essentials, Surgex, Slim Trim)

http://finance.yahoo.com/news/inergetics-showcases-superior-product-marketing-140000613.html


NEW GOLD STANDARD:

The current market is mostly confined to online sales and a few dispensaries and as recently reported, many of those products were found to be very inconsistent and unsafe, along with very unreliable results due to impurities and poor manufacturing practices. Inergetics unprecedented approach will be the first of its kind to deliver a new gold standard that will play a huge role in setting the new standard for the entire medical marijuana industry. A standard that physicians can and will trust. It will also quickly take them to a market leadership status behind their First-To-Market strategy that will get CBD products on retail shelves across the US.

http://sanfrancisco.cbslocal.com/2014/11/17/medicinal-marijuana-pot-weed-legal-medical-dispensary-sugerman-edibles-thc-potency-test-california-high-drugs-cannabis-dea/

http://mmjbusinessdaily.com/former-dixie-employee-blasts-cbd-industry-former-employer/

http://www.thedailychronic.net/2014/37614/hemp-oil-hustlers-project-cbd-investigates-makers-of-rsho/

http://learnaboutsam.org/wp-content/uploads/2013/05/CBD-brochure5.pdf

http://greenly.me/medical-marijuana-cannabis-understanding-cannabinoids-lab-facts/


CBD Research & Studies:

Cannabinoids are proving to be a great source to fight cancer, reducing inflammation, and control pain, to name just a few. The cannabinoid studies coming in are surprising everyone with their results and exciting the medical professionals who are looking for a more safe and effective treatment for their patients. Click on the link below to see for yourself the facts about Cannabinoids and the therapeutic uses they are proving to be effective for.
Emerging Clinical Applications For Cannabis & Cannabinoids - A Review of the Recent Scientific Literature, 2000 — 2013




MANAGEMENT:

Inergetics has a management team led by Michael. James, the CEO, who created & acquired 5 new brands (Bikini Ready, Slim Trim, Martha Stewart Essentials, OM Essentials, & Intrinsix), while also reformulating their one existing brand (Surgex), in the last 2 1/2 years, since taking over. He has a vast experience in the finance world and sports a squeaky clean reputation that is a real rarity in the OTC markets. His experience will play a very big role as they successfully leverage the competitive advantages they developed over the past year in the CBD arena. He has also created a partnership with Terra Tech, where he serves as their CFO, to provide the necessary highest quality extracted cannabinoids and cannabidoil that are essential in creating their best-of-class quality CBD supplements. He was also burdened with failed past management's debt that he restructured over a year ago. He is now moving the company forward with a much needed new product line with big growth potential and high profit margins and in a brand new sector, that is expected to be the fastest growing sector for the next 5 years. This new development is exactly what the company needed to quickly turn things around here to reduce their debt through strong sales growth and high profit margins. A REAL GAME CHANGER!

SUMMARY:

You can't ignore these facts that are validated through the various sources I provided. Us shareholders can really benefit from this knowledge as this year unfolds with their unprecedented approach that will take the CBD market by storm. Few are currently aware of what is happening with this small company that I just pointed out, but come March 26th, that will forever change, as the investing world will finally be made aware of this big opportunity. With only around 168 million OS shares it won't take a whole lot of buying to push this back up to a fair valuation. Do your DD and stay grounded with the facts when deciding on your investment strategy for this undiscovered and undervalued gem!

TECHNICAL OVERVIEW:

From a technical perspective, the weekly chart clearly shows where NRTI should get to this spring, which is in the $.07 to $.12 range. Longer term I can see them getting back above $.30 when they have their CBD products on store shelves across the US. The stock really took a beating after the MMJ Index topped out last spring, as did all the mj related stocks, but the selling for NRTI was extremely overdone, presenting a great entry right now that could land you 500% or greater returns! Opportunities like this don't come along that often and I believe those who get in at this entry level will see the biggest returns in the short term and even more in the longer term. My advice is to sell 1/2 after it doubles, so you can ride with free shares and zero risk. Cheers!